Caspase 8 gene variants in healthy North Indian population and comparison with worldwide ethnic group variations

Indian Journal of Human Genetics

Volumn 16, Issue 3, 2010, Pages 144-148

  George, Ginu P ^a   Mittal, Rama D ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Caspase; ethnicity; haplotype; PCR RFLP

Indexed keywords

CASPASE 8;

AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC GROUP; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; NORMAL HUMAN;

EID: 78650167763     PISSN: 09716866     EISSN: 1998362X     Source Type: Journal    
DOI: 10.4103/0971-6866.73406     Document Type: Article

References (20)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
2. MacPherson G, Healey CS, Teare MD, Balasubramanian SP, Reed MW, Pharoah PD, et al. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2004;96:1866-9.
3. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-8.
4. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000;21:485-95.
5. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005;55:178-94.
6. Liu B, Zhang Y, Jin M, Ni Q, Liang X, Ma X, et al. Association of Selected Polymorphisms of CCND1, p21, and caspase8 with Colorectal Cancer Risk. Mol Carcinog 2010;49:75-84.
7. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
8. Son JW, Kang HK, Chae MH, Choi JE, Park JM, Lee WK, et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet 2006;169:121-7.
9. Li C, Zhao H, Hu Z, Liu Z, Wang LE, Gershenwald JE, et al. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Human Mutation 2008;29:1443-51.
10. Hu Z, Li C, Chen K, Wang LE, Sturgis EM, Spitz MR, et al. Single nucleotide polymorphisms in selectedapoptotic genes and BPDE-induced apoptotic capacity in apparently normal primary lymphocytes: A genotype-phenotype correlation analysis. J Cancer Epidemiol 2008;2008:147905. [in press]
11. Frank B, Rigas SH, Bermejo JL, Wiestler M, Wagner K, Hemminki K, et al. The CASP8-652 6N del promoter polymorphism and breast cancer risk: A multicenter study. Breast Cancer Res Treat 2008;111:139-44.
12. Wang M, Zhang Z, Tian Y, Shao J. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer. Clin Cancer Res 2009;15:2567-72.
13. Cybulski C, Wokoorczyk D, Gliniewicz B, Sikorski A, Gorski B, Jakubowska A, et al. A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res Treat 2008;112:367-8.
14. Kittles RA, Weiss KM. Race, ancestry, and genes: Implications for defining disease risk. Annu Rev Genomics Hum Genet 2003;4:33-67.
15. Cooke GS, Hill AV. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001;2:967-77.
16. Dean M, Carrington M, O'Brien SJ. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 2002;3:263-92.
17. Jorde LB, Watkins WS, Kere J, Nyman D, Eriksson AW. Gene mapping in isolated populations: New roles for old friends? Hum Hered 2000;50:57-65.
18. Braun L. Race, ethnicity, and health: Can genetics explain disparities? Perspect Biol Med 2002;45:159-74.
19. Foster MW, Sharp RR. Race, ethnicity, and genomics: Social classifications as proxies of biological heterogeneity. Genome Res 2002;12:844-50.
20. Lee S, Mountain J, Koenig B. The meanings of "race" in the new genomics: Implications for health disparities research. Yale J Health Policy Law Ethics 2001;1:33-75.